Abstract:A series of 7-phenyl-4,5,6,7-tetrahydrothieno[3,2-b]pyridine derivatives containing triazole and other heterocycle substituents (methyltriazole, tetrazole, and triazolone) is described. Two experimental methods, maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ), were used to evaluate the anticonvulsant activity of the target compounds. Moreover, the neurotoxicity (NT) was tested using the Rotarod test. 5-(4-Chlorophenyl)-4,5-dihydrothieno[2,3-e][1,2,4]triazolo[4,3-a]pyridine (6c) showed the best anticonvulsant activity. In the MES and PTZ experiments, the 50% effective dose (ED50) values of compound 6c were 9.5 and 20.5 mg/kg, respectively. From the therapeutic index (PI) values, 6c (MES and PTZ with PI values of 48.0 and 22.2, respectively) showed better safety than the clinical drugs carbamazepine (MES with PI value of 6.4) and ethosuximide (PTZ with PI value of 3.2). The biological activities of the compounds were verified by using molecular docking studies. Compound 6c showed significant interactions with residues at the benzodiazepine-binding site on gamma-aminobutyric acid A (GABA(A)) receptors. The results of in vivo GABA estimation and bicuculline-induced seizures showed that 6c may have an effect on the GABA system. The physicochemical and pharmacokinetic properties of the target compounds were predicted.

Synthesis and anticonvulsant activity evaluation of 6-phenyl-7H-[1,2,4] triazolo[3,4-b][1,3,4]thiadiazines

Synthesis and Anticonvulsant Activities of Some Triazolothiadiazole Derivatives

Synthesis and Anticonvulsant Activity of 7-Phenyl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-5(4h)-ones and Their Derivatives.

Synthesis and Anticonvulsant Activity Evaluation of 6-Substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine Derivatives

Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4h)-one and Its Derivatives

Synthesis and Anticonvulsant Evaluation of Some New 6-(Substituted-phenyl)thiazolo[3,2-b][1,2,4]triazole Derivatives in Mice.

Synthesis and Evaluation of the Anticonvulsant Activity of 8-Alkoxy-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine Derivatives.

Synthesis and Evaluation of Anticonvulsant Activities of 7‐phenyl‐4,5,6,7‐tetrahydrothieno[3,2‐b]pyridine Derivatives

Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.

Synthesis of Novel 7-Substituted-5-phenyl-[1,2,4]triazolo[1,5-a] Pyrimidines with Anticonvulsant Activity

Synthesis and Evaluation of Anticonvulsant Activities of Triazole- Incorporated Benzothiazoles

Synthesis and Anticonvulsant Evaluation of 3-Substituted-4-(4-hexyloxyphenyl)-4h-1,2,4-triazoles

Synthesis and Anticonvulsant Activity Evaluation of 6-Substituted-pyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine Derivatives

Synthesis of 5-Alkoxythieno[2,3-e][1,2,4]triazolo[4,3-c]pyrimidine Derivatives and Evaluation of Their Anticonvulsant Activities.

Synthesis and Evaluation of the Anticonvulsant Activity of 5-Alkylthio-4- Phenyl-2,4-dihydro-3h-1,2,4-triazol-3-one Derivatives

Synthesis and Evaluation of the Anticonvulsant Activities of 2,3-Dihydrophthalazine-1,4-dione Derivatives

Synthesis and anticonvulsant activity 6-alkoxy-[1,2,4]triazolo[3,4-a] phthalazin-3(2H)-ones

Synthesis and Anticonvulsant Activity of 7-Alkoxy-triazolo-[3, 4-B] Benzo[D]Thiazoles

Synthesis and Anticonvulsant Activity Evaluation of Some 1-Alkoxy-4-(1h- 1,2,4-Triazol-1-yl)phthalazines

Synthesis and anticonvulsant activity of 7-benzylamino-4, 5dihydro-[1,2,4] triazolo[4,3-a]quinolines

Synthesis and Anticonvulsant Activity Evaluation of Phthalazine and Heterocyclic Derivatives